Anticancer Nanotherapeutics in Clinical Trials: The Work behind Clinical Translation of Nanomedicine

The ultimate goal of nanomedicine has always been the generation of translational technologies that can ameliorate current therapies. Cancer disease represented the primary target of nanotechnology applied to medicine, since its clinical management is characterized by very toxic therapeutics. In thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Parodi, Alessandro, Kolesova, Ekaterina P., Voronina, Maya V., Frolova, Anastasia S., Kostyushev, Dmitry, Trushina, Daria B., Akasov, Roman, Pallaeva, Tatiana, Zamyatnin, Andrey A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9656556/
https://www.ncbi.nlm.nih.gov/pubmed/36362156
http://dx.doi.org/10.3390/ijms232113368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9656556/
https://www.ncbi.nlm.nih.gov/pubmed/36362156
http://dx.doi.org/10.3390/ijms232113368

Ejemplares similares